LENZ THERAPEUTICS, INC. Shares Outstanding (Cover Page)
LENZ THERAPEUTICS, INC. (LENZ) had Shares Outstanding (Cover Page) of 31.42 million shares as of 2026-08-05, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-05: Entity Common Stock, Shares Outstanding 31.42M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 31.35M shares.
- 2026-03-18: Entity Common Stock, Shares Outstanding 31.35M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 31.29M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-05 | 31.42M shares 10-Q · filed 2026-08-11 |
| 2026-05-05 | 31.35M shares 10-Q · filed 2026-05-11 |
| 2026-03-18 | 31.35M shares 10-K · filed 2026-03-24 |
| 2025-10-30 | 31.29M shares 10-Q · filed 2025-11-05 |
| 2025-07-24 | 28.52M shares 10-Q · filed 2025-07-30 |
| 2025-05-01 | 28.15M shares 10-Q · filed 2025-05-07 |
| 2025-03-12 | 27.54M shares 10-K · filed 2025-03-19 |
| 2024-10-31 | 27.50M shares 10-Q · filed 2024-11-06 |
| 2024-08-09 | 27.50M shares 10-Q · filed 2024-08-14 |
| 2024-05-03 | 25.53M shares 10-Q · filed 2024-05-08 |
| 2024-02-23 | 58.24M shares 10-K · filed 2024-02-27 |
| 2023-11-09 | 58.00M shares 10-Q · filed 2023-11-13 |
| 2023-08-10 | 57.98M shares 10-Q · filed 2023-08-14 |
| 2023-05-05 | 58.10M shares 10-Q · filed 2023-05-11 |
| 2023-04-20 | 58.22M shares 10-K/A · filed 2023-04-27 |
| 2023-03-14 | 58.16M shares 10-K · filed 2023-03-20 |
| 2022-11-04 | 58.15M shares 10-Q · filed 2022-11-09 |
| 2022-08-05 | 58.21M shares 10-Q · filed 2022-08-11 |
| 2022-05-05 | 57.97M shares 10-Q · filed 2022-05-12 |
| 2022-03-15 | 58.01M shares 10-K · filed 2022-03-21 |
| 2021-11-08 | 58.08M shares 10-Q · filed 2021-11-10 |
| 2021-08-09 | 58.08M shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |